USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Mackay Memorial Hospital

USPTO PatentsView assignee record — 40 granted patents across 23 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

40
Total patents granted
23
CPC technology areas
12.3
Avg claims per patent
-33%
5-year filing velocity

The verdict

Mackay holds 40 US patents across 23 technology areas — rank #8,074 of 50,000 tracked assignees.

#8,074
of 50,000 US assignees by volume
Top 40%
by Innovation Score (38.7/100)
12.3
avg claims per patent
-33%
filing velocity, last 5 yrs

Portfolio overview

MacKay Memorial Hospital has been granted 40 US utility patents between 2015 and 2025, placing MacKay Memorial Hospital at rank #8,074 across all assignees tracked by PlainPatent. This portfolio spans 23 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.3 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, MacKay Memorial Hospital is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 38.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 16 grants, compared with 24 in the 2015–2019 window — a -33% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. MacKay Memorial Hospital's 12.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 23 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark MacKay Memorial Hospital against peers pursuing similar technology classes.

How does MacKay compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows MacKay holds 40 patents — placing it at rank #8,074 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

MacKay's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

02468 20152016201720182019202020212022202320242025 2
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
MacKay Memorial Hospital patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 7.5%
2016 6 15.0%
2017 6 15.0%
2018 2 5.0%
2019 7 17.5%
2020 6 15.0%
2021 4 10.0%
2022 1 2.5%
2023 2 5.0%
2024 1 2.5%
2025 2 5.0%

Which technologies does MacKay Memorial Hospital patent most?

Top 15 of 23 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#8,074

Across all tracked assignees

Innovation Score

38.7 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does MacKay Memorial Hospital hold?
MacKay Memorial Hospital holds 40 US granted patents filed between 2015 and 2025, spanning 23 technology areas.
What is MacKay Memorial Hospital's Innovation Score?
MacKay Memorial Hospital has an Innovation Score of 38.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does MacKay Memorial Hospital focus on?
MacKay Memorial Hospital's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 19 patents. The company has filed patents in 23 CPC subclasses total.
Is MacKay Memorial Hospital's patent filing rate increasing or decreasing?
MacKay Memorial Hospital's recent filing velocity is -33% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for MacKay Memorial Hospital's patents?
MacKay Memorial Hospital's patents average 12.3 claims each. This falls within the standard range, providing solid legal coverage.
How is the MacKay Memorial Hospital patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

Mackay's 40 grants land it in the top 40% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Mackay ranks #8,074 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61K — see who else leads that technology area. A61K leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov